SIGNAL TRANSDUCTION IN BIPOLAR ILLNESS
双相情感障碍中的信号转导
基本信息
- 批准号:6042274
- 负责人:
- 金额:$ 24.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-15 至 2002-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from applicant's abstract): The pathophysiology of bipolar
affective disorder (BAD) is not well understood, although its symptoms can be
effectively treated with lithium ion and other mood stabilizing agents. In both
animal and human studies, we have observed that lithium impairs the activation
of protein kinase C (PKC), an enzyme that is stimulated by receptor-mediated
formation of diacylglycerol and catalyzes the phosphorylation of many important
neuronal proteins. In studies utilizing both platelets and postmortem brains
from BAD subjects, we have noted increases in both membrane- associated PKC and
in translocation of the enzyme in response to stimulation of cell surface
receptors. As part of an attempt to understand the underlying mechanism for
these changes, we examined receptor-mediated activation of membrane G proteins
in BAD subjects. Enhanced coupling between serotonin receptors and G proteins
was found in brains of BAD. These results suggest that the altered affect that
characterizes BAD may be associated with an exaggerated transinembrane
signaling in one or more neurotransmitter pathways and that lithium exerts its
therapeutic action by suppressing receptor initiated transmembrane signal flow.
The aim of the proposed investigation is to continue to test the hypothesis
that BAD is related to enhanced G protein-mediated transmembrane signaling and
that the mood stabilizing drugs elicit . t their therapeutic efficacy by
reducing the transduction of signals initiated by G protein-coupled
neurotransmitter receptors. Specifically, in the proposed experiments we plan
to (1) directly assess in postmortem brain regions of BAD subjects, the
coupling of serotonin and a, adrenergic receptors to G proteins both under
basal and receptor stimulated conditions and explore the potential mechanisms
which may contribute to the altered coupling in BAD brains and (2) define the
specific mechanisms which contribute to the elevation in membrane associated
PKC activity BAD. To this end we plan to investigate RACK I protein expression
as well as calpain and activated calpain levels in BAD brains. We will also (3)
assess platelet G protein functions and PKC activity in BAD subjects before and
during treatment with mood stabilizing drugs in an_attempt to further test
these parameters as markers of therapeutic response.
描述(摘自申请者摘要):双相情感障碍的病理生理学
情感障碍(BAD)目前还不清楚,尽管其症状可能是
用锂离子和其他情绪稳定剂有效治疗。在这两个地方
动物和人类的研究,我们已经观察到锂削弱了激活
蛋白激酶C(PKC),一种由受体介导的刺激酶
二酰甘油的形成和催化许多重要的磷酸化
神经元蛋白质。在利用血小板和死后大脑进行的研究中
从不良受试者中,我们注意到膜相关蛋白激酶C和
在响应细胞表面刺激的酶的移位中
感受器。作为试图理解以下基本机制的一部分
在这些变化中,我们研究了受体介导的膜G蛋白的激活
在不好的科目里。5-羟色胺受体与G蛋白的偶联作用增强
在坏人的大脑中被发现。这些结果表明,这些改变会影响
不良的特征可能与夸张的跨膜有关
在一个或多个神经递质通路中的信号传递,以及锂在
抑制受体启动的跨膜信号流的治疗作用。
拟议的调查的目的是继续检验这一假设
BAD与增强的G蛋白介导的跨膜信号和
稳定情绪的药物所引发的。通过测试他们的治疗效果
减少G蛋白偶联引发的信号转导
神经递质受体。具体地说,在拟议的实验中,我们计划
为了(1)直接评估不良受试者的死后脑区,
5-羟色胺和肾上腺素能受体与G蛋白的偶联
基础刺激和受体刺激条件及其可能机制的探讨
这可能有助于坏大脑中改变的耦合和(2)定义
膜相关膜升高的特定机制
PKC活动不正确。为此,我们计划研究Rack I蛋白的表达
以及坏大脑中的钙蛋白酶和激活的钙蛋白酶水平。我们还将(3)
评估不良受试者的血小板G蛋白功能和蛋白激酶C活性
在治疗期间服用稳定情绪的药物,试图进一步测试
这些参数可作为治疗反应的标志。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EITAN FRIEDMAN其他文献
EITAN FRIEDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EITAN FRIEDMAN', 18)}}的其他基金
DOPAMINE-LINKED PHOSPHOINOSITIDE METABOLISM IN BRAIN
脑中多巴胺连接的磷酸肌醇代谢
- 批准号:
2839337 - 财政年份:1998
- 资助金额:
$ 24.8万 - 项目类别:
PRENATAL COCAINE AND DOPAMINE RECEPTOR SIGNALING
产前可卡因和多巴胺受体信号传导
- 批准号:
6175490 - 财政年份:1998
- 资助金额:
$ 24.8万 - 项目类别:
PRENATAL COCAINE AND DOPAMINE RECEPTOR SIGNALING
产前可卡因和多巴胺受体信号传导
- 批准号:
6549360 - 财政年份:1998
- 资助金额:
$ 24.8万 - 项目类别:
相似海外基金
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
- 批准号:
6110455 - 财政年份:1999
- 资助金额:
$ 24.8万 - 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
- 批准号:
6273039 - 财政年份:1998
- 资助金额:
$ 24.8万 - 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
- 批准号:
6242449 - 财政年份:1997
- 资助金额:
$ 24.8万 - 项目类别:
Central and renal alpha-adrenergic receptor with the development of salt-induced hypertension in Dahl-Iwai salt-sensitive rats.
中枢和肾脏 α-肾上腺素能受体与 Dahl-Iwai 盐敏感大鼠中盐诱导高血压的发展。
- 批准号:
03670461 - 财政年份:1991
- 资助金额:
$ 24.8万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
IDENTIFICATION AND FUNCTION OF ALPHA-ADRENERGIC RECEPTOR
α-肾上腺素能受体的鉴定和功能
- 批准号:
3079007 - 财政年份:1983
- 资助金额:
$ 24.8万 - 项目类别: